You are here

Home

News

News

City Therapeutics, founded on Kotaro Nakanishi’s Ohio State research, secures $1 billion collaboration with Biogen

Read More
    Showing 76-80 of 122 results

    04.16.2021 — News

    Ohio State celebrates the impact of research and innovation

    During the annual Research and Innovation Showcase on April 15, Ohio State recognized the impact of research, creative inquiry and innovation at the university and beyond. Learn more about the event and those recognized, including the Innovators of the Year.

    During the annual Research and Innovation Showcase on April 15, Ohio State recognized the impact of research, creative inquiry and innovation at the university and beyond. Learn more about the event and those recognized, including the Innovators of the Year.

    04.12.2021 — Events

    2021 Research and Innovation Showcase to be held April 15

    This Thursday! Join us for our annual celebration of the impacts of research and creative inquiry at Ohio State and beyond. The Research and Innovation Showcase will provide an opportunity to hear directly from senior leadership about research and innovation achievements as well as plans for the enterprise moving forward. Researchers will share inspiring spotlight talks, and the event will culminate in the awarding of Ohio State’s Innovators of the Year.

    This Thursday! Join us for our annual celebration of the impacts of research and creative inquiry at Ohio State and beyond. The Research and Innovation Showcase will provide an opportunity to hear directly from senior leadership about research and innovation achievements as well as plans for the enterprise moving forward. Researchers will share inspiring spotlight talks, and the event will culminate in the awarding of Ohio State’s Innovators of the Year.

    04.07.2021 — Startups

    Two more Ohio State startups acquired

    Two more startups spun out of Ohio State technology have been acquired - Innovate IP and TransChart.

    Two more startups spun out of Ohio State technology have been acquired - Innovate IP and TransChart.

    04.05.2021 — Startups

    Ohio State startup Entrada Therapeutics announces $116M in new funding

    Entrada Therapeutics Inc., a privately held biotechnology company based on research created at Ohio State, announced $116 million in new investment that will support treatment of multiple neuromuscular diseases, led by Duchenne muscular dystrophy.

    Entrada Therapeutics Inc., a privately held biotechnology company based on research created at Ohio State, announced $116 million in new investment that will support treatment of multiple neuromuscular diseases, led by Duchenne muscular dystrophy.

    04.02.2021 — News

    New organizational structure brings together Ohio State’s research, innovation and knowledge ecosystem

    The Ohio State University recently announced structural changes that will provide stronger supports for our entrepreneurial and business community while also better connecting our world-class researchers to the resources they need to translate their research discoveries into economically and socially viable innovations.

    The Ohio State University recently announced structural changes that will provide stronger supports for our entrepreneurial and business community while also better connecting our world-class researchers to the resources they need to translate their research discoveries into economically and socially viable innovations.